China Resources Medical Holdings Company Limited (1PH) — Cash Flow Reinvestment Rate
China Resources Medical Holdings Company Limited (1PH) has a Cash Flow Reinvestment Rate of 0.57x as of June 2023, reinvesting €155.33 Million (capex €96.85 Million plus investments €58.49 Million) from operating cash flow of €270.22 Million. See cash generation quality of China Resources Medical Holdings Company to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
China Resources Medical Holdings Company Limited Cash Flow Reinvestment Rate (2016–2025)
Historical reinvestment intensity for China Resources Medical Holdings Company Limited across 10 annual periods. For the full cash flow conversion analysis, see China Resources Medical Holdings Company operating cash flow efficiency.
Annual Cash Flow Reinvestment Rate for China Resources Medical Holdings Company Limited (2016–2025)
Year-by-year capital reinvestment analysis for China Resources Medical Holdings Company Limited. See 1PH free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.38x | €514.94 Million | €1.36 Billion | €514.13 Million | ▼ -14.7% |
| 2024 | 0.44x | €564.75 Million | €1.27 Billion | €563.69 Million | ▼ -61.2% |
| 2023 | 1.15x | €1.37 Billion | €1.20 Billion | €486.68 Million | ▲ +131.4% |
| 2022 | 0.50x | €310.21 Million | €626.58 Million | €252.87 Million | ▼ -72.8% |
| 2021 | 1.82x | €1.29 Billion | €710.43 Million | €198.43 Million | ▲ +216.8% |
| 2020 | 0.58x | €370.34 Million | €643.69 Million | €209.55 Million | ▲ +21.9% |
| 2019 | 0.47x | €172.73 Million | €366.05 Million | €36.37 Million | ▼ -61.1% |
| 2018 | 1.21x | €405.67 Million | €334.15 Million | €57.61 Million | ▼ -6.6% |
| 2017 | 1.30x | €597.53 Million | €459.54 Million | €34.50 Million | ▲ +78.7% |
| 2016 | 0.73x | €162.86 Million | €223.79 Million | €42.45 Million | — |